We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.51 | 1.20% | 127.30 | 127.90 | 125.99 | 126.34 | 3,312,459 | 01:00:00 |
Form 20-F [X]
|
Form 40-F [ ]
|
Yes [ ]
|
No [X]
|
|
Number of
B shares
|
Average
purchase price
|
Transaction
value, DKK
|
Accumulated, last announcement
|
4,349,481
|
|
1,273,628,489
|
2 March 2015
|
195,000
|
317.58
|
61,927,652
|
3 March 2015
|
210,000
|
316.45
|
66,455,214
|
4 March 2015
|
195,000
|
314.46
|
61,318,901
|
5 March 2015
|
180,000
|
317.58
|
57,164,292
|
6 March 2015
|
210,000
|
321.12
|
67,435,851
|
Accumulated under the programme
|
5,339,481
|
|
1,587,930,398
|
Media: | ||
Anne Margrethe Hauge
|
+45 3079 3450
|
amhg@novonordisk.com
|
|
|
|
Investors: | ||
Kasper Roseeuw Poulsen
|
+45 3079 4303
|
krop@novonordisk.com
|
Jannick Lindegaard Denholt
|
+45 3079 8519
|
jlis@novonordisk.com
|
Daniel Bohsen
|
+45 3079 6376
|
dabo@novonordisk.com
|
Melanie Raouzeos
|
+45 3075 3479
|
mrz@novonordisk.com
|
Frank Daniel Mersebach (US)
|
+1 609 235 8567
|
fdni@novonordisk.com
|
Novo Nordisk A/S
Investor Relations
|
Novo Allé
2880 Bagsværd
Denmark
|
Telephone:
+45 4444 8888
|
Internet:
www.novonordisk.com
24 25 67 90
|
Company announcement No 17 / 2015
|
Date: March 9, 2015
|
NOVO NORDISK A/S
Lars Rebien Sørensen,
Chief Executive Officer
|
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions